International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,478 | -10,479 | -9,833 | -9,171 | -12,723 |
| Depreciation Amortization | 458 | 464 | 474 | 494 | 289 |
| Accounts receivable | -147 | -55 | -133 | 599 | -608 |
| Accounts payable and accrued liabilities | 128 | -421 | 197 | 302 | -256 |
| Other Working Capital | 336 | -681 | 9 | 42 | -179 |
| Other Operating Activity | 5,288 | 5,534 | 2,597 | 770 | 6,528 |
| Operating Cash Flow | $-6,415 | $-5,638 | $-6,689 | $-6,964 | $-6,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -289 | -167 | -190 | -565 | -300 |
| Purchase Sale Intangibles | -698 | -729 | -596 | -376 | -324 |
| Other Investing Activity | -698 | -729 | -596 | -376 | -324 |
| Investing Cash Flow | $-987 | $-896 | $-786 | $-941 | $-624 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,988 | 8,924 | 2,088 | 3,890 | 10,646 |
| Dividend Paid | N/A | N/A | -237 | -430 | -429 |
| Other Financing Activity | 2,282 | -801 | 4,941 | 0 | 2,411 |
| Financing Cash Flow | $6,270 | $8,123 | $6,792 | $3,460 | $12,628 |
| Beginning Cash Position | 2,243 | 654 | 1,337 | 5,782 | 727 |
| End Cash Position | 1,111 | 2,243 | 654 | 1,337 | 5,782 |
| Net Cash Flow | $-1,132 | $1,589 | $-683 | $-4,445 | $5,055 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,415 | -5,638 | -6,689 | -6,964 | -6,949 |
| Capital Expenditure | -290 | -167 | -197 | -565 | -300 |
| Free Cash Flow | -6,705 | -5,805 | -6,886 | -7,529 | -7,249 |